NCT01025934View on ClinicalTrials.gov

Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy

PHASE4CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Proliferative Diabetic Retinopathy

Interventions

DRUG

Bevacizumab

OTHER

sham

All Listed Sponsors

collaborator

Napoli CTO Hospital

UNKNOWN

lead

University of Campania Luigi Vanvitelli

OTHER

NCT01025934 - Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy | Biotech Hunter | Biotech Hunter